Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Expands robotics to 20+ specialities
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Rocuronium Bromide Injection is a neuromuscular blocking agent
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
he product will be launched shortly in the US market.
Subscribe To Our Newsletter & Stay Updated
